Treatment Policy for Maxillary Sinus Carcinoma

Abstract

Cases (908) of malignant tumors of the nose and paranasal sinuses treated from 1957-1974 were statistically analyzed. The most common tumor site was the maxillary sinus (91.4%) and the most common histological type was carcinoma (92.4%). The crude and relative survival rates for each treatment mode were calculated in Jan., 1975. The number of cases and the 5 yr relative survival rates of the main groups were listed. The stage grouping of maxillary sinus carcinoma based on the classification of tumor spread in the TNM [tumor, node, metastasis] system was recommended for the comparison of survival rates. The best mode of treatment was the combination of 60Co .gamma.-ray irradiation and continuous intraarterial infusion of 5-FU [5-fluorouracil]. Curettage during irradiation is recommended. Maxillectomy should be performed only for irradiation failure cases.